Latest news
Latest news
Here you can explore the latest news on pancreatic cancer, the charity, and our supporters.
The content you will find here includes updates, and insights that help raise awareness and support our mission in the fight against pancreatic cancer.
Tribute to Andy Rourke: The Smiths' bassist honoured after pancreatic cancer battle
A powerful tribute is in the works for the late Andy Rourke, The Smiths’ beloved bassist, who tragically passed away in May 2023 after battling pancreatic cancer.
Read more
Critical Advice on PERT Shortages
There is a currently a global shortage of vital medication for pancreatic cancer patients and survivors. Failing to have a consistent supply of this medication can have serious consequences on the quality of life of those patients.
Read more
Pancreatic Cancer breakthrough: Potential cure on the horizon
Pancreatic cancer survival rates have barely improved in 50 years and has the worst prognosis of any common cancer, claiming on average 9,500 lives a year in the UK. However, a recent breakthrough in research could potentially provide a cure.
Read more
Important Creon information
If you have been prescribed Creon, we would like to inform you that Mylan the marketing authorisation holder for Creon, has decided to voluntarily discontinue the manufacture and distribution of Creon 40,000 from June 2019..
Read more
New research: medicinal cannabis could improve survival rates of pancreatic cancer
A study published this week (Oncogene Journal) found that mice with pancreatic cancer survive nearly three times longer if medical cannabis was added to their chemotherapy treatment.
Read more
Life-extending pancreatic cancer drug finally wins NICE approval
We are absolutely delighted to announce that NICE has given the green light to Abraxane®, a drug that can extend the lives of pancreatic cancer patients. This means that patients in England will be able to have access to the drug.
Read more
New recipe book launched for pancreatic cancer patient
Pancreatic Cancer Action has launched a recipe book to help alleviate one of the key side effects of pancreatic cancer: the inability to maintain weight and a nutritional balance.
Read more
Reappraisal of life-extending drug Abraxane
NICE, the institute that provides national guidance and advice to improve health and social care in England and Wales, will reappraise Abraxane® for treating metastatic pancreatic cancer.
Read more
10 year survival rates improving for most cancers but sadly not pancreatic cancer
On World Cancer Day, Cancer Research UK released new statistics to show that cancer deaths are falling with ten year survival rates of some cancers improving significantly since 1971.
Read more
Obesity increases pancreatic cancer risk
You may have seen in the news today that the ‘obesity epidemic’ could lead to an additional 670,000 cancer cases over the next 20 years, including pancreatic cancer.
Read more
Abraxane (nab-paclitaxel) plus gemcitabine shown to improve survival in metastatic pancreatic cancer
Celgene UK and Ireland's Phase III trial shows Abraxane plus gemcitabine significantly improves survival in metastatic pancreatic cancer patients.
Read more